Predictors of Incomplete Occlusion following Pipeline Embolization of Intracranial Aneurysms: Is It Less Effective in Older Patients?

References

1. 1.↵
   2. McDowell MM,
   3. Feroze RA,
   4. Ducruet AF

   . Pipeline Embolization Device: long-term outcome data flows in. World Neurosurg 2016;85:6–7 doi:10.1016/j.wneu.2015.12.001 pmid:26679263

   CrossRefPubMed
2. 2.↵
   Health C for D and R: Recently-Approved Devices: Pipeline^TM Embolization Device, P100018. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/UCM442242.pdf. Accessed August 9, 2016.
3. 3.↵
   2. Adeeb N,
   3. Griessenauer CJ,
   4. Moore J, et al

   . Pipeline embolization device for recurrent cerebral aneurysms after microsurgical clipping. World Neurosurg 2016;93:341–45 doi:10.1016/j.wneu.2016.06.065 pmid:27350300

   CrossRefPubMed
4. 4.↵
   2. Becske T,
   3. Kallmes DF,
   4. Saatci I, et al

   . Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology 2013;267:858–68 doi:10.1148/radiol.13120099 pmid:23418004

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Griessenauer CJ,
   3. Ogilvy CS,
   4. Foreman PM, et al

   . Pipeline Embolization Device for small intracranial aneurysms: evaluation of safety and efficacy in a multicenter cohort. Neurosurgery 2017;80:579–87 doi:10.1227/NEU.0000000000001377 pmid:27489165

   CrossRefPubMed
6. 6.↵
   2. Kühn AL,
   3. Hou SY,
   4. Perras M, et al

   . Flow diverter stents for unruptured saccular anterior circulation perforating artery aneurysms: safety, efficacy, and short-term follow-up. J Neurointerv Surg 2015;7:634–40 doi:10.1136/neurintsurg-2014-011237 pmid:25051964

   Abstract/FREE Full Text
7. 7.↵
   2. Lin N,
   3. Brouillard AM,
   4. Keigher KM, et al

   . Utilization of Pipeline embolization device for treatment of ruptured intracranial aneurysms: US multicenter experience. J Neurointerv Surg 2015;7:808–15 doi:10.1136/neurintsurg-2014-011320

   Abstract/FREE Full Text
8. 8.↵
   2. Nelson PK,
   3. Lylyk P,
   4. Szikora I, et al

   . The Pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol 2011;32:34–40 doi:10.3174/ajnr.A2421 pmid:21148256

   Abstract/FREE Full Text
9. 9.↵
   2. Jabbour P,
   3. Chalouhi N,
   4. Tjoumakaris S, et al

   . The Pipeline Embolization Device: learning curve and predictors of complications and aneurysm obliteration. Neurosurgery 2013;73:113–20; discussion 120 doi:10.1227/01.neu.0000429844.06955.39 pmid:23615106

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Attali J,
    3. Benaissa A,
    4. Soize S, et al

    . Follow-up of intracranial aneurysms treated by flow diverter: comparison of three-dimensional time-of-flight MR angiography (3D-TOF-MRA) and contrast-enhanced MR angiography (CE-MRA) sequences with digital subtraction angiography as the gold standard. J Neurointervl Surg 2016;8:81–86 doi:10.1136/neurintsurg-2014-011449 pmid:25352582

    Abstract/FREE Full Text
11. 11.↵
    2. Boddu SR,
    3. Tong FC,
    4. Dehkharghani S, et al

    . Contrast-enhanced time-resolved MRA for follow-up of intracranial aneurysms treated with the Pipeline embolization device. AJNR Am J Neuroradiol 2014;35:2112–18 doi:10.3174/ajnr.A4008 pmid:24994828

    Abstract/FREE Full Text
12. 12.↵
    2. Chen JX,
    3. Lai LF,
    4. Zheng K, et al

    . Influencing factors of immediate angiographic results in intracranial aneurysms patients after endovascular treatment. J Neurol 2015;262:2115–23 doi:10.1007/s00415-015-7824-2 pmid:26100332

    CrossRefPubMed
13. 13.↵
    2. Ogilvy CS,
    3. Chua MH,
    4. Fusco MR, et al

    . Validation of a system to predict recanalization after endovascular treatment of intracranial aneurysms. Neurosurgery 2015;77:168–73; discussion 173–74 doi:10.1227/NEU.0000000000000744 pmid:25850603

    CrossRefPubMed
14. 14.↵
    2. Ogilvy CS,
    3. Chua MH,
    4. Fusco MR, et al

    . Stratification of recanalization for patients with endovascular treatment of intracranial aneurysms. Neurosurgery 2015;76:390–95; discussion 395 doi:10.1227/NEU.0000000000000651 pmid:25621984

    CrossRefPubMed
15. 15.↵
    2. O'Kelly CJ,
    3. Spears J,
    4. Chow M, et al

    . Canadian experience with the Pipeline embolization device for repair of unruptured intracranial aneurysms. AJNR Am J Neuroradiol 2013;34:381–87 doi:10.3174/ajnr.A3224 pmid:22859284

    Abstract/FREE Full Text
16. 16.↵
    2. Yu SC,
    3. Kwok CK,
    4. Cheng PW, et al

    . Intracranial aneurysms: midterm outcome of Pipeline embolization device—a prospective study in 143 patients with 178 aneurysms. Radiology 2012;265:893–901 doi:10.1148/radiol.12120422 pmid:22996749

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Sturiale CL,
    3. Brinjikji W,
    4. Murad MH, et al

    . Endovascular treatment of intracranial aneurysms in elderly patients a systematic review and meta-analysis. Stroke 2013;44:1897–902 doi:10.1161/STROKEAHA.113.001524 pmid:23686977

    Abstract/FREE Full Text
18. 18.↵
    2. Ferns SP,
    3. Sprengers ME,
    4. van Rooij WJ, et al

    . Coiling of intracranial aneurysms: a systematic review on initial occlusion and reopening and retreatment rates. Stroke 2009;40:e523–29 doi:10.1161/STROKEAHA.109.553099 pmid:19520984

    Abstract/FREE Full Text
19. 19.↵
    2. Pouratian N,
    3. Oskouian RJ Jr.,
    4. Jensen ME, et al

    . Endovascular management of unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 2006;77:572–78 doi:10.1136/jnnp.2005.078469 pmid:16614015

    Abstract/FREE Full Text
20. 20.↵
    2. Brinjikji W,
    3. Kallmes DF,
    4. Cloft HJ, et al

    . Age-related outcomes following intracranial aneurysm treatment with the Pipeline Embolization Device: a subgroup analysis of the IntrePED registry. J Neurosurg 2016;124:1726–30 doi:10.3171/2015.5.JNS15327 pmid:26544776

    CrossRefPubMed
21. 21.↵
    2. Rouchaud A,
    3. Johnson C,
    4. Thielen E, et al

    . Differential gene expression in coiled versus flow-diverter-treated aneurysms: RNA sequencing analysis in a rabbit aneurysm model. AJNR Am J Neuroradiol 2016;37:1114–21 doi:10.3174/ajnr.A4648 pmid:26721773

    Abstract/FREE Full Text
22. 22.↵
    2. Puffer C,
    3. Dai D,
    4. Ding YH, et al

    . Gene expression comparison of flow diversion and coiling in an experimental aneurysm model. J Neurointerv Surg 2015;7:926–30 doi:10.1136/neurintsurg-2014-011452 pmid:25332413

    Abstract/FREE Full Text
23. 23.↵
    2. Kadirvel R,
    3. Ding YH,
    4. Dai D, et al

    . Cellular mechanisms of aneurysm occlusion after treatment with a flow diverter. Radiology 2014;270:394–99 doi:10.1148/radiol.13130796 pmid:24086073

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Szikora I,
    3. Turányi E,
    4. Marosfoi M

    . Evolution of flow-diverter endothelialization and thrombus organization in giant fusiform aneurysms after flow diversion: a histopathologic study. AJNR Am J Neuroradiol 2015;36:1716–20 doi:10.3174/ajnr.A4336 pmid:26251428

    Abstract/FREE Full Text
25. 25.↵
    2. Madonna R,
    3. Novo G,
    4. Balistreri CR

    . Cellular and molecular basis of the imbalance between vascular damage and repair in ageing and age-related diseases: as biomarkers and targets for new treatments. Mech Ageing Dev 2016;159:22–30 doi:10.1016/j.mad.2016.03.005 pmid:26993150

    CrossRefPubMed
26. 26.↵
    2. Yousef H,
    3. Morgenthaler A,
    4. Schlesinger C, et al

    . Age-associated increase in BMP signaling inhibits hippocampal neurogenesis. Stem Cells 2015;33:1577–88 doi:10.1002/stem.1943 pmid:25538007

    CrossRefPubMed
27. 27.↵
    2. Griessenauer CJ,
    3. Gupta R,
    4. Shi S, et al

    . Collar sign in incompletely occluded aneurysms after Pipeline embolization: evaluation with angiography and optical coherence tomography. AJNR Am J Neuroradiol 2017;38:323–26 doi:10.3174/ajnr.A5010 pmid:28056454

    Abstract/FREE Full Text
28. 28.↵
    2. Andreasen TH,
    3. Bartek J Jr.,
    4. Andresen M, et al

    . Modifiable risk factors for aneurysmal subarachnoid hemorrhage. Stroke 2013;44:3607–12 doi:10.1161/STROKEAHA.113.001575 pmid:24193807

    FREE Full Text
29. 29.↵
    2. Brinjikji W,
    3. Lingineni RK,
    4. Gu CN, et al

    . Smoking is not associated with recurrence and retreatment of intracranial aneurysms after endovascular coiling. J Neurosurg 2015;122:95–100 doi:10.3171/2014.10.JNS141035 pmid:25380112

    CrossRefPubMed
30. 30.↵
    2. Juvela S,
    3. Hillbom M,
    4. Numminen H, et al

    . Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke 1993;24:639–46 doi:10.1161/01.STR.24.5.639 pmid:8488517

    Abstract/FREE Full Text
31. 31.↵
    2. Ortiz R,
    3. Stefanski M,
    4. Rosenwasser R, et al

    . Cigarette smoking as a risk factor for recurrence of aneurysms treated by endosaccular occlusion. J Neurosurg 2008;108:672–75 doi:10.3171/JNS/2008/108/4/0672 pmid:18377244

    CrossRefPubMed
32. 32.↵
    2. Athyros VG,
    3. Katsiki N,
    4. Doumas M, et al

    . Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Curr Med Res Opin 2013;29:1263–74 doi:10.1185/03007995.2013.827566 pmid:23879722

    CrossRefPubMed
33. 33.↵
    2. Rouchaud A,
    3. Brinjikji W,
    4. Cloft HJ, et al

    . Smoking does not affect occlusion rates and morbidity-mortality after Pipeline embolization for intracranial aneurysms. AJNR Am J Neuroradiol 2016;37:1122–26 doi:10.3174/ajnr.A4664 pmid:26797135

    Abstract/FREE Full Text
34. 34.↵
    2. Aigner A,
    3. Grittner U,
    4. Rolfs A, et al

    . Contribution of established stroke risk factors to the burden of stroke in young adults. Stroke 2017;48:1744–51 doi:10.1161/STROKEAHA.117.016599 pmid:28619986

    Abstract/FREE Full Text
35. 35.↵
    2. Lemesle G,
    3. Tricot O,
    4. Meurice T, et al

    . Incident myocardial infarction and very late stent thrombosis in outpatients with stable coronary artery disease. J Am Coll Cardiol 2017;69:2149–56 doi:10.1016/j.jacc.2017.02.050 pmid:28449776

    FREE Full Text
36. 36.↵
    2. Salazar Adum JP,
    3. Fuentes HE,
    4. Lind BB, et al

    . Predictors of active cancer thromboembolic outcomes: mortality associated with calf deep vein thrombosis. Int Angiol 2017 May 24. [Epub ahead of print] doi:10.23736/S0392-9590.17.03846-9 pmid:28541021

    CrossRefPubMed